女性生殖健康:经典血液科医生需要了解的内容
本综述总结了血液科医生在女性生殖健康寿命期间应关注的关键过渡期和时间点,包括月经初潮、妊娠、绝经和性别肯定医疗,讨论了这些生命转折如何影响患有终生或暂时性血液疾病的患者,重点关注抗凝治疗对月经出血的影响、性别肯定医疗中的血栓风险,以及妊娠对镰状细胞病和遗传性出血性疾病患者的影响。
要点
- 血液科医生应关注女性患者月经初潮、妊娠、绝经和性别肯定医疗等关键节点。
- 抗凝治疗可能影响月经出血,需评估铁缺乏风险。
- 性别肯定医疗中需关注血栓风险,妊娠对镰状细胞病和遗传性出血性疾病患者有影响。
核心结论
- 血液科医生需准备应对女性生殖健康寿命期间的关键过渡期,以提供安全公平的医疗。
研究设计与样本
- 综述,总结女性生殖健康各阶段对血液疾病患者的影响。
主要发现
- 月经初潮、妊娠、绝经和性别肯定医疗可能影响血液疾病患者,包括增加铁缺乏伴或不伴贫血的风险。
- 抗凝治疗影响月经出血,性别肯定医疗存在血栓风险,妊娠对镰状细胞病和遗传性出血性疾病患者有影响。
临床怎么用
- 血液科医生应关注女性患者生殖健康各阶段的特殊需求,评估铁缺乏、血栓风险及妊娠影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Haematologists should be prepared to address several key transitions and timepoints during the female reproductive health lifespan to provide safe and equitable care for all patients with haematological disorders. In this Review, we summarise important points for recognition and consideration in the care of patients with lifelong or transient haematological conditions. We include discussions on menarche, pregnancy, menopause, and gender-affirming care, and how these life transitions might impact people with underlying haematological disorders, including an increased risk of iron deficiency with or without anaemia. We focus specifically on the impacts of anticoagulation on menstrual bleeding, thrombosis risk on gender-affirming care, and pregnancy on those with sickle cell disease and inherited bleeding disorders.
引用
- Bannow BS, Akpan I, Baldwin MK, et al. Female reproductive health-what the classical haematologist needs to know. Lancet Haematol. 2026. PMID: 42302802. doi:10.1016/S2352-3026(26)00110-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。